Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Post by august202013on Sep 25, 2024 11:34am
65 Views
Post# 36240298

OBJECTIVE TO RESET MIR MGT MINDSET

OBJECTIVE TO RESET MIR MGT MINDSET Medmira management must try to reset MINDSET and set strategic planning moving forward taking into account previous experiences with big brother's true colours and also closer here at home.

Challenge it is a rat race actually in medmira business who can come up with a workable testing kit FIRST and market it QUICKLY and move to next one when that marketing/demand curve starts to move downwards. With that sales proceeds can pay down loans and advances the rebuilding your financial muscles..... fast forward can even go into share buy back.


So perhaps if syphilis test kit is already proven reliable just try to flood the market Africa Asia l the market get your marketing director/CFO pack their bags go visit Ghana/Nigeria... contact their private hospitals go test your product on their patients and showcase your 3 minutes test kit and get their orders on the spot and shipped to them by priority AIR shipping. You can follow-up from your next destination country and even consider turning back to visit them after their shipment arrives.

BUT have to move and start with the first step to PLAN today. 
<< Previous
Bullboard Posts